B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 23, 2010, Pages 10644-10648

  Johnson III, Burles A ^a   Kahler, David J ^a,c   Baban, Babak ^a   Chandler, Phillip R ^a   Kang, Baolin ^a   Shimoda, Michiko ^a   Koni, Pandelakis A ^a   Pihkala, Jeanene ^a   Vilagos, Bojan ^b   Busslinger, Meinrad ^b   Munn, David H ^a   Mellor, Andrew L ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^c New York Stem Cell Foundation   (United States)

Author keywords

B cells; CD19; T cell regulation

Indexed keywords

CD19 ANTIBODY; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR PAX5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CELL MATURATION; DENDRITIC CELL; GENE EXPRESSION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN CELL;

ANIMALS; ANTIGENS, CD19; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; CELL LINEAGE; DENDRITIC CELLS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MICE; MICE, KNOCKOUT; SPLEEN; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 9;

MUS;

EID: 77953729583     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0914347107     Document Type: Article

References (42)

1. Mellor AL, Munn DH (2008) Creating immune privilege: Active local suppression that benefits friends, but protects foes. Nat Rev Immunol 8:74-80.
2. Munn DH, Mellor AL (2007) Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 117:1147-1154.
3. Popov A, et al. (2006) Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J Clin Invest 116:3160-3170.
4. van der Sluijs KF, et al. (2006) Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. J Infect Dis 193:214-222.
5. Boasso A, Shearer GM (2007) How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation. Curr Drug Metab 8:217-223. (Pubitemid 46628287)
6. Guillonneau C, et al. (2009) Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc Natl Acad Sci USA 106:3330-3335.
7. Reddy P, et al. (2008) Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J Clin Invest 118:2562-2573.
8. + cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. Am J Respir Cell Mol Biol 30:311-318.
9. + T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression. J Immunol 183:1022-1031.
10. Mellor AL, Munn DH (2004) IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol 4:762-774.
11. Fallarino F, Gizzi S, Mosci P, Grohmann U, Puccetti P (2007) Tryptophan catabolism in IDO+ plasmacytoid dendritic cells. Curr Drug Metab 8:209-216.
12. Munn DH, et al. (2002) Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297:1867-1870.
13. + dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling. J Immunol 175:5601-5605.
14. Chen W, Liang X, Peterson AJ, Munn DH, Blazar BR (2008) The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol 181:5396-5404.
15. + dendritic cells. Eur J Immunol 37:1064-1071.
16. Baban B, et al. (2005) A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. Int Immunol 17:909-919. (Pubitemid 41417958)
17. Kozmik Z, Wang S, Dörfler P, Adams B, Busslinger M (1992) The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol Cell Biol 12:2662-2672.
18. Nutt SL, Morrison AM, Dörfler P, Rolink A, Busslinger M (1998) Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J 17:2319-2333. (Pubitemid 28171916)
19. Fuxa M, Busslinger M (2007) Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity function. J Immunol 178:3031-3037. (Pubitemid 46333183)
20. Cobaleda C, Jochum W, Busslinger M (2007) Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449:473-477. (Pubitemid 47509547)
21. Cisse B, et al. (2008) Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135:37-48.
22. Kwon K, et al. (2008) Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development. Immunity 28:751-762.
23. Muller AJ, et al. (2008) Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase. Proc Natl Acad Sci USA 105:17073-17078.
24. Munn DH, et al. (2004) Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 114:280-290. (Pubitemid 39071633)
25. Yazawa N, et al. (2003) CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes. Blood 102:1374-1380. (Pubitemid 36988046)
26. Carter RH, Fearon DT (1992) CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105-107.
27. Depoil D, et al. (2008) CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat Immunol 9:63-72. (Pubitemid 350286205)
28. Harwood NE, Batista FD (2008) New insights into the early molecular events underlying B cell activation. Immunity 28:609-619.
29. Mellor AL, et al. (2004) Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. Int Immunol 16:1391-1401.
30. Baban B, et al. (2009) IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 183:2475-2483.
31. Kitamura D, Roes J, Kühn R, Rajewsky K (1991) A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350:423-426. (Pubitemid 21912244)
32. Chen J, et al. (1993) Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int Immunol 5:647-656. (Pubitemid 23209419)
33. Sharma MD, et al. (2007) Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest 117:2570-2582.
34. Pelayo R, et al. (2005) Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow. Blood 105:4407-4415. (Pubitemid 40720788)
35. Racine R, Chatterjee M, Winslow GM (2008) CD11c expression identifies a population of extrafollicular antigen-specific splenic plasmablasts responsible for CD4 T-independent antibody responses during intracellular bacterial infection. J Immunol 181:1375-1385.
36. Vinay DS, Kim CH, Chang KH, Kwon BS (2010) PDCA expression by B lymphocytes reveals important functional attributes. J Immunol 184:807-815.
37. Sato S, Ono N, Steeber DA, Pisetsky DS, Tedder TF (1996) CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J Immunol 157:4371-4378. (Pubitemid 126449355)
38. Rickert RC, Rajewsky K, Roes J (1995) Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352-355.
39. Haas KM, Poe JC, Steeber DA, Tedder TF (2005) B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23:7-18.
40. You Y, Zhao H, Wang Y, Carter RH (2009) Cutting edge: Primary and secondary effects of CD19 deficiency on cells of the marginal zone. J Immunol 182:7343-7347.
41. Watanabe R, et al. (2007) CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol 171:560-570. (Pubitemid 47344688)
42. Matsushita T, et al. (2006) Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Am J Pathol 168:812-821. (Pubitemid 43327734)